PartV. Who is Responsible?
HARVEYA.K. WHITNEY, JR. W hen a patient is harmed or dies as a result of a medication error, who should be held ac countable? Should it be the physician, phar macist, nurse, or all three? There are very clear areas of demarcation when one professional is singularly in volved; for example, when the physician not only pre scribes but administers the medication. The answer be comes more difficult to determine when the physician prescribes, the pharmacist dispenses, and the nurse ad ministers it. With more health professionals involved in the process, the problem is less likely to be easily solved. Now that both physicians' assistants and nurse practitioners are prescribing and admiriistering medica tions, and pharmacy technicians are dispensing them, a cobweb of entangled health professionals has evolved that could tie the courts up attempting to determine who is guilty in any given situation.
My thesis is that pharmacy professionals, i.e., phar macists and technicians, must assert their position as being responsible for what happens to patients with re gard to drug therapy. We must not shy away from our responsibility but rather we should seek to be held ac countable. However, this means we also must be pre pared and equipped for our responsibility.
Our schools of pharmacy are preparing pharmacists with more intensive instruction on drugs than ever be fore in history. The pharmacist's knowledge of pharma cotherapy far surpasses that of any other health profes sional. Each year we are developing more and bettereducated pharmacy technicians. The level of sophistica tion of pharmacy services with modern technology is taking quantum leaps. Advances in computers have as sisted us in making it possible to control the vast amount of information that we must be aware of to provide a high level of pharmacy services to patients. The benefits of these changes in pharmacy and their impact on patient care can be seen by looking at just one example. The case was the much publicized death of Libby Zion that happened in the New York Hospital in March 1984. If it were repeated today, one would be lieve that the outcome would be quite different. My first supposition is that in 1984 the New York Hospital did not have a 24-hour clinical pharmacy service, and consequently there was no intervention by the pharma cist in this case. Had there been, the patient may not have been given an injection of meperidine which pur portedly led to "hyperpyrexia and sudden collapse" and subsequently death. The patient, Libby Zion, an 18year-old woman, was admitted to the hospital's medi cal service at 2:00 a.m., more than two hours after hav ing been treated in the emergency room by a secondyear medical resident. The diagnosis was "viral syn drome with hysterical symptoms." The resident recom mended, among other things, that her phenelzine be discontinued and that meperidine 25 mg be "given for agitation and shivering." Ms. Zion had been taking phenelzine since January 1984 when she began therapy for stress, although she had stopped it the day of her admission because she "had felt too ill." 1
The courts will not continue to allow pharmacists who are licensed to protect the public to escape their responsibility.
The potential interaction between monoamine oxi dase inhibitors, such as phenelzine, and meperidine was reported as early as 1968; 2 therefore, my second supposition is that this would have been recognized if the pharmacy service had had in place a computerized order entry system as it exists today. The operation of the system today would alert pharmacy professionals of this interaction, and a clinical pharmacist could have advised the physician of the risk involved. When I spoke recently to the pharmacy director of the New York Hospital, W. James Bicket, he pointed out that in patients are now well served by pharmacy, and ambu latory care, including the emergency department, is high on pharmacy's agenda for the future. Whether the order for meperidine was given by the resident while Libby Zion was still in the emergency room or after she was admitted to the medical service is unclear, but the fact remains that pharmacy care is needed wherever patients are treated. One cannot deny that had this event occurred in the emergency room today, and if no pharmacy intervention was possible, then the hospital would be open to serious liability charges.
The evidence of the cause of Libby Zion's death was not well established; however, this does not negate the fact that pharmacy professionals must be involved to prevent harm to patients receiving medications.
The grand jury for the Libby Zion case found five contributing circumstances that led to her death, one of which was that she "had been given a dose of meperi dine despite the physician's knowledge of her history of treatment with phenelzine." It is interesting that one of the recommendations of the grand jury's report was:
The State Department of Health should conduct a study to deter mine the feasibility of requiring level one hospitals to implement a computerized system to check for contraindicated combinations of drugs. 1 The fact that this was done and the system is in place should be a message to all pharmacy professionals that they must be equally prepared. The courts will not con tinue to allow pharmacists who are licensed to protect the public to escape their responsibility. The court in this case might have found the physician guilty because he prescribed the medication, but they did not. Had this been a clear case of death by prescribing the wrong medication, would they have found him guilty? Should he have known or, at least, tried to determine if there could be an interaction? Anyone who knows the extent of a physician's knowledge of medications as compared to a pharmacist's, should fix the onus on the pharma cist. The public may not be fully aware of the difference yet, but when they are informed our laws should be changed to make the pharmacist responsible. Until then state pharmacy boards will only concern themselves with violations in the practice act as it now stands, which unfortunately, in many states, still defines the role of the pharmacist as a dispenser of drugs.
The profession must support the change of laws to redefine the roles of pharmacists and technicians before a Libby Zion-type case occurs wherein there is no doubt that pharmacy was negligent. Negligent because pharmacists did not assert their proper role-they did not act to protect the patient from harm by medications prescribed. Pharmacists need to redirect their attention from dispensing to the pharmacotherapy needs of pa tients and concomitantly assisting physicians. As I stat ed in an earlier editorial, technicians must be given more education and fraining, and legal authority to be come the dispensing technologists of the future. 3 I am proposing that pharmacy be given legal authori ty to prevent medication errors, and that the profession accept responsibility for medication errors even when the error is clearly the fault of the prescriber initiating an incorrect order. Pharmacist intervention is required to prevent harm to the patient when the physician is in error, and the pharmacist is the professional most quali fied to make the ultimate decision in such situations. To support pharmacy, it has been recommended that:
Policies and procedures should be formulated by the institution as a support system for pharmacists when the need arises to question physician prescribing.
and that:
The institution should ensure that medication orders are reviewed by pharmacists prior to the administration of any medication to the patient, as a system of checks and balances. 4 In this issue, Koren, Reich, and Hales report the re sults of an interesting study of intervention by clinical pharmacists (see page 219). Among other things, they indicate the occurrence of four errors in the prescribed order "could have caused serious morbidity or mortali ty" had the pharmacist not intervened. 5 
